Peracetic Acid: Technology, Supply Chain, and Market Dynamics

July 29, 2025

The global peracetic acid market, valued at USD 941.66 million in 2024 and projected to grow at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2034, is increasingly shaped by divergent regional regulatory frameworks, public health infrastructure, and evolving industrial hygiene standards. While demand remains globally consistent due to the compound’s broad-spectrum antimicrobial efficacy, regional manufacturing trends reveal stark contrasts in production capacity, supply resilience, and market penetration strategies. North America, led by the United States, dominates with approximately 38% of global consumption, driven by stringent food safety regulations under the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA), which endorse peracetic acid (PAA) for use in poultry, red meat, and fresh produce processing. The EPA’s Safer Choice program further incentivizes adoption in industrial cleaning, positioning PAA as a preferred alternative to chlorine-based disinfectants due to its lower environmental persistence and absence of harmful disinfection byproducts such as trihalomethanes.

Europe presents a more fragmented but equally dynamic landscape, where regulatory oversight is harmonized under the Biocidal Products Regulation (BPR) administered by the European Chemicals Agency (ECHA). Germany and France lead in industrial and municipal wastewater treatment applications, with PAA usage mandated in certain effluent discharge protocols to meet EU Urban Wastewater Treatment Directive standards. However, cross-border supply chains face logistical constraints due to PAA’s instability in concentrated forms, necessitating on-site generation or regional blending hubs to minimize transport risks. This has led to a surge in decentralized production models, particularly in Scandinavia, where NCH Europe and Evoqua Water Technologies have deployed mobile electrochemical generation units at municipal treatment plants—reducing dependency on bulk shipments and enhancing operational safety. The EU’s REACH regulation further influences formulation practices, requiring full lifecycle toxicity assessments that have accelerated the shift toward stabilized, low-residue PAA blends.

In Asia Pacific, demand is being propelled by rapid urbanization, expanding food processing sectors, and rising healthcare expenditures, particularly in India and Southeast Asia. Japan, under the Ministry of Health, Labour and Welfare (MHLW), has long permitted PAA in food contact applications, and recent amendments to the Food Sanitation Act now encourage its use in sushi preparation and seafood export facilities to meet international phytosanitary standards. China, while historically reliant on chlorine-based disinfectants, is transitioning toward PAA in response to the Ministry of Ecology and Environment’s (MEE) 2023 directive limiting halogenated byproduct emissions from industrial effluents. However, regional manufacturing trends in China remain centralized, with major producers like Zhejiang Juhua Co., Ltd. and Shandong Fengcai Chemical operating large-scale integrated facilities in Zhejiang and Shandong provinces, creating supply bottlenecks during regional environmental crackdowns. India, by contrast, is witnessing a surge in localized production, supported by the Department of Chemicals and Petrochemicals’ Production Linked Incentive (PLI) scheme, which includes disinfectants under its critical domestic manufacturing push.

Latin America and Africa exhibit nascent but high-potential markets, where market penetration strategies are increasingly tied to public-private partnerships. In Brazil, ANVISA’s 2022 approval of PAA for hospital sterilization has opened new avenues in healthcare, while South Africa’s Department of Water and Sanitation is piloting PAA-based disinfection in rural water schemes to combat cholera outbreaks—highlighting its role in low-infrastructure settings. However, import dependency and cold-chain logistics for stabilized formulations remain key restraints, prompting companies like Solvay and PeroxyChem to explore regional tolling agreements with local chemical formulators to reduce costs and improve accessibility. These efforts underscore the growing importance of cross-border supply chains that balance regulatory compliance, shelf-life limitations, and cost efficiency.

Geopolitical factors further influence regional competitiveness. U.S. sanctions on certain Russian chemical imports have redirected trade flows toward Southeast Asian and Middle Eastern suppliers, while the Indo-Pacific Economic Framework includes provisions for harmonizing biocide standards, potentially easing market entry for compliant producers. As regional manufacturing trends evolve toward decentralization and regulatory alignment, the ability to adapt formulation, packaging, and distribution to local conditions will determine long-term market viability.